Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to demonstrate the safety and the feasibility of this device, and its ability to increase venous blood flow

Primary safety Endpoint:

To demonstrate the safety of the device- no serious adverse effect

Primary feasibility Endpoint:

Increase the blood flow velocity

The blood flow will be detected by a Duplex Ultrasonography test at the popliteal vein and the femoral vein.

The volunteers will rest at controlled environment room . Measurements will be performed after 30 min of rest without the device on the leg (baseline) and after 30 min of device activity .


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03330925
Study type Interventional
Source ElastiMed ltd
Contact
Status Completed
Phase N/A
Start date January 24, 2018
Completion date December 3, 2018

See also
  Status Clinical Trial Phase
Completed NCT04096729 - Patients Commitment to Compression Therapy
Terminated NCT05212363 - Lower Leg Compression in Extended Video Game Play: A Pilot Study N/A
Completed NCT03725111 - Haemodynamics Variations of Transcutaneous Oxygen in Patient With Areterio-venous Leg Ulcers Under Venous Compression N/A
Recruiting NCT04837560 - Safety and Efficacy of the ElastiMed's SACS 2.0 - Smart Active Compression Stocking for the Treatment of Venous Edema Phase 1